The 2005 Scientific Sessions of the American Heart Association (AHA).
Francis
Darrel
D
St Mary's Hospital and National Heart and Lung Institute, London, UK.
D000572:American Heart Association; D000818:Animals; D002316:Cardiotonic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D006333:Heart Failure / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation; D006699:Home Care Services; D006801:Humans; D006835:Hydrazones / Q000494:pharmacology* / Q000627:therapeutic use; D008991:Monitoring, Physiologic / Q000295:instrumentation; D009203:Myocardial Infarction / Q000628:therapy*; D010138:Pacemaker, Artificial; D011724:Pyridazines / Q000494:pharmacology* / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D000077464:Simendan; D016896:Treatment Outcome; D014481:United States
D002316:Cardiotonic Agents; D006835:Hydrazones; D011724:Pyridazines; D000077464:Simendan